Pharm D started in India not to produce graduates for foreign countries like US or UK: Dr Pawar Lack of knowledge about the standard and the scope of employment opportunities of the international course on pharmacy practice, Pharm D, have contributed significantly to the rising concerns of certain academicians about the programme, said Dr. Atmaram Pawar, member of the Pharm ... Read More »

Glenmark bullish on drug discovery pipeline, eyes partnerships HYDERABAD: As many as six out of seven molecules in Glenmark’s drug discovery pipeline are currently in the clinical trial stage and the company’s R&D spend pegged at 10 per cent of sales is expected to be maintained at similar levels for next two years, a top official has said. Pain, inflammation ... Read More »

A Social Experiment — Real Story An insightful reality –read it till the end.   A man sat at a metro station in Washington DC and started to play the violin; it was a cold January morning. He played six Bach pieces for about 45 minutes. During that time, since it was rush hour, it was calculated that thousand of ... Read More »

British healthcare delegation to visit India   LONDON: To help strengthen the UK-India partnership in the healthcare sector, a dozen British organisations representing British healthcare industry will be visiting the country. Lord Ajay Kumar Kakkar, UK Government Trade Ambassador will call on senior representatives from the Ministry of Health and Family Welfare and offer to collaborate with India’s healthcare system. ... Read More »

9 Ways to Nail Your Next Job Interview As the old adage goes, “dress for success.” An interviewer will rarely deduct points for dressing up. For men and women, play it safe — a nice conservative suit should do the trick. And please, leave the jeans at home. Don’t slouch. Maintain eye contact. Smile. Your body language will tell the ... Read More »

Shares of Ranbaxy Laboratories and Sun Pharma MUMBAI: Shares of Ranbaxy Laboratories and Sun Pharma attracted buying interest today after the companies received the US Federal Trade Commission’s clearance for their $ 4 billion merger plan. Ranbaxy Laboratories rose by 2.37 per cent to settle at Rs 720.35 on the BSE. In intra-day trade, it jumped 3.46 per cent to ... Read More »

Lupin gets USFDA approval for diarrhoea drug NEW DELHI: Drug major Lupin has received approval from the US health regulator to sell a generic version of Vancocin capsules, used in treating diarrhoea, in the American market. The company has received final approval for its Vancomycin Hydrochloride Capsules in strengths of 125 mg and 250 mg from the US Food and ... Read More »

Ways to handle stress Lessens when shared, mounts up when curbed! Usually people hide the reasons of their stress from others. They do not want others to get perturbed because of them. They prefer that others do not get to know their personal affairs nor their shortcomings .They feel that if they are undergoing a rough patch, others might think ... Read More »

Ranbaxy forfeits 180 days exclusivity for generic Nexium NEW DELHI: RanbaxyBSE 1.49 % Laboratories has lost the opportunity to exclusively market in the United States for six months the first generic version of Anglo Swedish drug innovator Astra Zeneca’s heartburn drug Nexium, the Delhi-based company said in a filing to the stock exchange on Tuesday. The company, which is in ... Read More »

 Life is not a Race — Stay away from unhealthy Competition   I was cycling and noticed a person in front of me, about 1/4 of Km. I could tell he was cycling a little slower than me and I decided to try to cat…ch him. I had about a km to go on the road before turning off. So ... Read More »